DBV Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
CEODaniel Tassé
CEODaniel Tassé
Employees125
Employees125
HeadquartersChatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded2002
Founded2002
Employees125
Employees125
DBVT Key Statistics
Market cap1.15B
Market cap1.15B
Price-Earnings ratio-3.89
Price-Earnings ratio-3.89
Dividend yield—
Dividend yield—
Average volume266.06K
Average volume266.06K
High today$21.12
High today$21.12
Low today$19.89
Low today$19.89
Open price$20.21
Open price$20.21
Volume242.54K
Volume242.54K
52 Week high$26.19
52 Week high$26.19
52 Week low$6.00
52 Week low$6.00
DBVT News
TipRanks 6d
DBV Technologies price target raised to $47 from $45 at CitizensCitizens raised the firm’s price target on DBV Technologies (DBVT) to $47 from $45 and keeps an Outperform rating on the shares. DBV Technologies remains on tra...
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.